KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Assets (2016 - 2025)

Medpace Holdings' Current Assets history spans 11 years, with the latest figure at $989.6 million for Q4 2025.

  • For Q4 2025, Current Assets fell 3.85% year-over-year to $989.6 million; the TTM value through Dec 2025 reached $989.6 million, down 3.85%, while the annual FY2025 figure was $989.6 million, 3.85% down from the prior year.
  • Current Assets reached $989.6 million in Q4 2025 per MEDP's latest filing, up from $737.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.0 billion in Q3 2024 to a low of $328.9 million in Q2 2022.
  • Average Current Assets over 5 years is $615.5 million, with a median of $572.0 million recorded in 2021.
  • Peak YoY movement for Current Assets: plummeted 51.66% in 2022, then soared 130.26% in 2024.
  • A 5-year view of Current Assets shows it stood at $690.9 million in 2021, then tumbled by 51.66% to $334.0 million in 2022, then soared by 77.81% to $593.8 million in 2023, then surged by 73.32% to $1.0 billion in 2024, then decreased by 3.85% to $989.6 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Current Assets are $989.6 million (Q4 2025), $737.3 million (Q3 2025), and $520.8 million (Q2 2025).